Nuvation Bio’s president, CEO, and founder discusses the company’s mission, approach to developing a global strategy, and how it manages its increasing pipeline.
David Hung
Advertisement
David Hung is president, CEO, and founder of Nuvation Bio.
Articles by David Hung
Nuvation CEO David Hung discusses his leadership style, success stories for building camaraderie, and his inspiration for joining the pharma and biotech industry.
David Hung, CEO of Nuvation Bio, details the company’s ongoing trials for new drugs and new indications for existing molecules.
Nuvation’s CEO David Hung details the various cancer medications the company has on the market and in clinical trials.
David Hung, CEO of Nuvation Bio, explains the company’s current focus on US operations and how it utilizes partners for global impact.
Nuvation Bio’s CEO David Hung discusses the how Nuvation built a relatiohsip with Daichii Sankyo.
David Hung, Nuvation Bio’s CEO, explains the company’s focus on providing patients with better drugs.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data
2
Why Real-Time Data Analytics Are Vital for the Next Evolution of Clinical Trials
3
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s
4
M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK
5